甲状腺癌中miR-222关键靶基因预测及其信号通路分析
[17]Xiang D，Tian B，Yang T，et al.miR-222 expression is correlated with the ATA risk stratifications in papillary thyroid carcinomas[J].Medicine (Baltimore)，2019，98(25)：e16050.
[18]Ekambaram P，Lee JL，Hubel NE，et al.The CARMA3-Bcl10-MALT1 Signalosome Drives NFkappaB Activation and Promotes Aggressiveness in AngiotensinⅡReceptor-Positive Breast Cancer[J].Cancer Res，2018，78(5)：1225-1240.
[19]Papaggelopoulos J，Angelopoulou A，Avgoustidis D，et al.Association of Polymorphisms in the Genes of Angiotensinogen and Angiotensin Receptors With Risk for Basal Cell Carcinoma[J].Anticancer Res，2019，39(10)：5525-5530.
[20]Uemura H，Ishiguro H，Nakaigawa N，et al.Angiotensin Ⅱ receptor blocker shows antiproliferative activity in prostate cancer cells： a possibility of tyrosine kinase inhibitor of growth factor[J].Mol Cancer Ther，2003，2(11)：1139-1147.
[21]Zhang Q，Yu S，Lam MMT，et al.Angiotensin Ⅱ promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress[J].J Exp Clin Cancer Res，2019，38(1)：116.
收稿日期：2019-10-01;修回日期：2019-10-21
編辑/成森, 百拇医药(黄琪峰 郑琳琳 张菁)
[18]Ekambaram P，Lee JL，Hubel NE，et al.The CARMA3-Bcl10-MALT1 Signalosome Drives NFkappaB Activation and Promotes Aggressiveness in AngiotensinⅡReceptor-Positive Breast Cancer[J].Cancer Res，2018，78(5)：1225-1240.
[19]Papaggelopoulos J，Angelopoulou A，Avgoustidis D，et al.Association of Polymorphisms in the Genes of Angiotensinogen and Angiotensin Receptors With Risk for Basal Cell Carcinoma[J].Anticancer Res，2019，39(10)：5525-5530.
[20]Uemura H，Ishiguro H，Nakaigawa N，et al.Angiotensin Ⅱ receptor blocker shows antiproliferative activity in prostate cancer cells： a possibility of tyrosine kinase inhibitor of growth factor[J].Mol Cancer Ther，2003，2(11)：1139-1147.
[21]Zhang Q，Yu S，Lam MMT，et al.Angiotensin Ⅱ promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress[J].J Exp Clin Cancer Res，2019，38(1)：116.
收稿日期：2019-10-01;修回日期：2019-10-21
編辑/成森, 百拇医药(黄琪峰 郑琳琳 张菁)